8-KEarnings & ResultsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Feb 3, 2021)

Filed February 3, 2021For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed an 8-K on February 3, 2021, primarily to announce its financial results for the fourth quarter and full year ended December 31, 2020. The press release, furnished as Exhibit 99.1, provides key details on the company's operational and financial performance during this period. Investors should review this press release for a comprehensive understanding of the reported results, which may include revenue, earnings, and other financial metrics that impact the company's valuation and future outlook. This filing serves as the official notification of these results, and while not deemed "filed" for certain legal purposes, it represents crucial information for market participants. Investors interested in BSX's performance in late 2020 and its financial condition at year-end should consult the attached press release for specific figures and management commentary.

Key Highlights

  • 1Boston Scientific announced its Q4 and full-year 2020 financial results on February 3, 2021.
  • 2The results were disclosed via a press release furnished as Exhibit 99.1 with the 8-K filing.
  • 3The filing is primarily informational, providing investors with access to the earnings release.
  • 4Item 2.02 of the 8-K covers Results of Operations and Financial Condition.
  • 5Item 9.01 details the exhibits, including the press release (Exhibit 99.1) and the Cover Page Interactive Data File (Exhibit 104).
  • 6The information is not deemed "filed" for certain SEC purposes, but is crucial for investors to review.
  • 7Investors are directed to the press release for specific financial performance details for the period ending December 31, 2020.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and provide access to Boston Scientific Corporation's financial results for the fourth quarter and full year ended December 31, 2020, through an accompanying press release.

The specific financial results are detailed in the press release issued by Boston Scientific Corporation dated February 3, 2021, which is furnished as Exhibit 99.1 to this 8-K filing.

This 8-K filing itself does not contain audited financial statements. It serves to announce results via a press release. The press release would typically contain key financial figures, but for full audited statements, investors should refer to the company's subsequent Form 10-K filing for the fiscal year 2020.

When information in an 8-K is furnished and not deemed 'filed,' it means the company is providing the information to the public but is not subject to the same liability under Section 18 of the Exchange Act as if it were formally filed. However, it remains critical information for investors to consider when making investment decisions.